Literature DB >> 31449725

Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice.

Yougang Zhai1, Adil J Haresi1, Lee Huang1, Deborah Lang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31449725      PMCID： PMC6928400          DOI： 10.1111/pcmr.12821

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  11 in total

1.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

2.  Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.

Authors:  Kurtis B Reed; Jerry D Brewer; Christine M Lohse; Kariline E Bringe; Crystal N Pruitt; Lawrence E Gibson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

3.  Gender differences in melanoma survival: female patients have a decreased risk of metastasis.

Authors:  Arjen Joosse; Esther de Vries; Renate Eckel; Tamar Nijsten; Alexander M M Eggermont; Dieter Hölzel; Jan Willem W Coebergh; Jutta Engel
Journal:  J Invest Dermatol       Date:  2010-12-09       Impact factor: 8.551

4.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

5.  Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

Authors:  Konstantinos Lasithiotakis; Ulrike Leiter; Friedegund Meier; Thomas Eigentler; Gizela Metzler; Matthias Moehrle; Helmut Breuninger; Claus Garbe
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

6.  Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.

Authors:  Joseph L Bundy; Cynthia Vied; Crystal Badger; Richard S Nowakowski
Journal:  J Comp Neurol       Date:  2018-11-08       Impact factor: 3.215

7.  Targeting BRAFV600E in an inducible murine model of melanoma.

Authors:  Anna I Hooijkaas; Jules Gadiot; Martin van der Valk; Wolter J Mooi; Christian U Blank
Journal:  Am J Pathol       Date:  2012-07-11       Impact factor: 4.307

8.  Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors.

Authors:  Christopher A Natale; Elizabeth K Duperret; Junqian Zhang; Rochelle Sadeghi; Ankit Dahal; Kevin Tyler O'Brien; Rosa Cookson; Jeffrey D Winkler; Todd W Ridky
Journal:  Elife       Date:  2016-04-26       Impact factor: 8.140

9.  Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.

Authors:  Christopher A Natale; Jinyang Li; Junqian Zhang; Ankit Dahal; Tzvete Dentchev; Ben Z Stanger; Todd W Ridky
Journal:  Elife       Date:  2018-01-16       Impact factor: 8.140

10.  Sex differences in the C57BL/6 model of Mycobacterium tuberculosis infection.

Authors:  Jannike Dibbern; Lars Eggers; Bianca E Schneider
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379
View more
  7 in total

1.  Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma.

Authors:  Gennie L Parkman; David A Kircher; Christopher M Stehn; Martin McMahon; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2020-11-11       Impact factor: 4.693

2.  Targeting Pan-ETS Factors Inhibits Melanoma Progression.

Authors:  Lee Huang; Yougang Zhai; Jennifer La; Jason W Lui; Stephen P G Moore; Elizabeth C Little; Sixia Xiao; Adil J Haresi; Candice Brem; Jag Bhawan; Deborah Lang
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 13.312

3.  YK-4-279 Attenuates Progression of Pre-Existing Pigmented Lesions to Nodular Melanoma in a Mouse Model.

Authors:  Lee Huang; Yougang Zhai; Cristian D Fajardo; Deborah Lang
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

4.  MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice.

Authors:  Sofie Martens; Nozomi Takahashi; Gillian Blancke; Niels Vandamme; Hanne Verschuere; Tatyana Divert; Marnik Vuylsteke; Geert Berx; Peter Vandenabeele
Journal:  Cell Death Dis       Date:  2022-04-14       Impact factor: 9.685

Review 5.  Let's talk about sex: A biological variable in immune response against melanoma.

Authors:  Panshak P Dakup; Adam J Greer; Shobhan Gaddameedhi
Journal:  Pigment Cell Melanoma Res       Date:  2022-02-03       Impact factor: 4.159

Review 6.  Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials.

Authors:  Kara T Kleber; Khurshid R Iranpur; Lauren M Perry; Sylvia M Cruz; Aryana M Razmara; William T N Culp; Michael S Kent; Jonathan A Eisen; Robert B Rebhun; Robert J Canter
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

7.  Strength of immune selection in tumors varies with sex and age.

Authors:  Andrea Castro; Rachel Marty Pyke; Xinlian Zhang; Wesley Kurt Thompson; Chi-Ping Day; Ludmil B Alexandrov; Maurizio Zanetti; Hannah Carter
Journal:  Nat Commun       Date:  2020-08-17       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.